Cargando…
A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma
OBJECTIVE: Few reports have described the real-world outcomes of rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) plus response-adapted whole-brain radiotherapy (WBRT) for elderly patients with primary central nervous system lymphoma (PCNSL). We evaluated the outcome of this regi...
Autores principales: | Suzuki, Yutaro, Imoto, Naoto, Ishihara, Shunichi, Fujiwara, Shinji, Ito, Rie, Sakai, Toshiyasu, Yamamoto, Satomi, Sugiura, Isamu, Kurahashi, Shingo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152862/ https://www.ncbi.nlm.nih.gov/pubmed/34670884 http://dx.doi.org/10.2169/internalmedicine.7805-21 |
Ejemplares similares
-
End-of-Life Care of Acute Myeloid Leukemia Compared with Aggressive lymphoma in Patients Who Are Eligible for Intensive Chemotherapy: An Observational Study in a Japanese Community Hospital
por: Kokaji, Masato, et al.
Publicado: (2023) -
Long-term follow-up after rituximab plus bendamustine in a patient with relapsed or refractory hairy cell leukemia variant: A case report
por: Imoto, Naoto, et al.
Publicado: (2021) -
CD79B
Y196 mutation is a potent predictive marker for favorable response to R‐MPV in primary central nervous system lymphoma
por: Yamaguchi, Junya, et al.
Publicado: (2022) -
Diffuse large B cell lymphoma primarily presenting as acute liver failure in a surviving patient
por: Shibata, Jumpei, et al.
Publicado: (2019) -
MPV17-related hepatocerebral mitochondrial DNA depletion syndrome (MPV17-NNH) revisited
por: Qualls, Clifford, et al.
Publicado: (2016)